Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
30(1)
Published: June 19, 2024
Abstract
Background
COVID-19
is
a
new
infectious
disease
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS
CoV-2).
Since
outbreak
in
December
2019,
it
has
an
unprecedented
world
pandemic,
leading
to
global
human
health
crisis.
Although
SARS
CoV-2
mainly
affects
lungs,
causing
interstitial
pneumonia
and
distress
syndrome,
number
of
patients
often
have
extensive
clinical
manifestations,
such
as
gastrointestinal
symptoms,
cardiovascular
damage
renal
dysfunction.
Purpose
This
review
article
discusses
pathogenic
mechanisms
provides
some
useful
suggestions
for
future
diagnosis,
treatment
prevention.
Methods
An
English-language
literature
search
was
conducted
PubMed
Web
Science
databases
up
12th
April,
2024
terms
“COVID-19”,
“SARS
CoV-2”,
“cardiovascular
damage”,
“myocardial
injury”,
“myocarditis”,
“hypertension”,
“arrhythmia”,
“heart
failure”
“coronary
heart
disease”,
especially
update
articles
2023
2024.
Salient
medical
literatures
regarding
were
selected,
extracted
synthesized.
Results
The
most
common
myocarditis
pericarditis,
hypertension,
arrhythmia,
myocardial
injury
failure,
coronary
disease,
stress
cardiomyopathy,
ischemic
stroke,
blood
coagulation
abnormalities,
dyslipidemia.
Two
important
may
be
direct
viral
cytotoxicity
well
indirect
hyperimmune
responses
body
infection.
Conclusions
Cardiovascular
portends
worse
prognosis.
underlying
pathophysiological
related
are
not
completely
clear,
two
SARSCoV-2
infection
responses.
iScience,
Journal Year:
2023,
Volume and Issue:
26(4), P. 106401 - 106401
Published: March 15, 2023
There
has
been
increasing
public
concern
that
COVID-19
vaccination
causes
menstrual
disturbance
regarding
the
relative
effect
of
compared
to
SARS-CoV-2
infection.
Our
objectives
were
test
potential
risk
factors
for
reporting
cycle
changes
following
and
compare
parameters
disease.
We
performed
a
secondary
analysis
retrospective
online
survey
conducted
in
UK
March
2021.
In
pre-menopausal
vaccinated
participants
(n
=
4,989),
18%
reported
after
their
first
vaccine
injection.
The
prevalence
any
was
higher
women
who
smoke,
have
history
disease,
or
are
not
using
estradiol-containing
contraceptives.
second
sample
including
both
unvaccinated
12,579),
alone
associated
with
abnormal
parameters,
while
disease
an
increased
heavier
bleeding,
"missed"
periods,
inter-menstrual
bleeding.
Hypertension,
Journal Year:
2023,
Volume and Issue:
80(10), P. 2135 - 2148
Published: Aug. 21, 2023
SARS-CoV-2
may
trigger
new-onset
persistent
hypertension.
This
study
investigated
the
incidence
and
risk
factors
associated
with
hypertension
during
COVID-19
hospitalization
at
≈6-month
follow-up
compared
influenza.This
retrospective
observational
was
conducted
in
a
major
academic
health
system
New
York
City.
Participants
included
45
398
patients
(March
2020
to
August
2022)
13
864
influenza
(January
2018
without
history
of
hypertension.At
6-month
follow-up,
seen
20.6%
hospitalized
10.85%
nonhospitalized
COVID-19.
Persistent
among
did
not
vary
across
pandemic,
whereas
that
decreased
from
20%
March
≈10%
October
(R2=0.79,
P=0.003)
then
plateaued
thereafter.
Hospitalized
were
2.23
([95%
CI,
1.48-3.54];
P<0.001)
times
1.52
1.22-1.90];
P<0.01)
more
likely
develop
than
counterparts.
common
older
adults,
males,
Black,
preexisting
comorbidities
(chronic
obstructive
pulmonary
disease,
coronary
artery
chronic
kidney
disease),
those
who
treated
pressor
corticosteroid
medications.
Mathematical
models
predicted
79%
86%
accuracy.
In
addition,
21.0%
no
prior
developed
hospitalization.Incidence
is
higher
influenza,
constituting
burden
given
sheer
number
Screening
at-risk
for
following
illness
be
warranted.
BMC Public Health,
Journal Year:
2021,
Volume and Issue:
21(1)
Published: May 31, 2021
Abstract
Background
The
impact
of
Covid-19
and
its
long-term
consequences
is
not
yet
fully
understood.
Sick
leave
can
be
seen
as
an
indicator
health
in
a
working
age
population,
the
present
study
aimed
to
investigate
sick-leave
patterns
after
Covid-19,
potential
factors
predicting
longer
sick
hospitalised
non-hospitalised
people
with
Covid-19.
Methods
comprehensive
national
registry-based
Sweden
4-month
follow-up.
All
who
started
receive
sickness
benefits
for
during
March
1
August
31,
2020,
were
included.
Predictors
≥1
month
long
Covid
(≥12
weeks)
analysed
logistic
regression
total
population
separate
models
depending
on
inpatient
care
due
Results
A
11,955
within
inclusion
period.
median
was
35
days,
13.3%
Covid,
9.0%
remained
whole
follow-up
There
2960
received
which
strongest
predictor
leave.
year
prior
older
also
predicted
No
clear
pattern
socioeconomic
noted.
Conclusions
substantial
number
are
may
protracted,
quite
common.
severity
(needing
care),
leave,
all
seem
predict
likelihood
However,
no
factor
could
clearly
indicating
complexity
this
condition.
group
needing
seems
heterogeneous,
knowledge
gap.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2021,
Volume and Issue:
unknown
Published: Nov. 23, 2021
Abstract
Background
There
has
been
increasing
public
concern
that
COVID-19
vaccines
cause
menstrual
cycle
disturbances,
yet
there
is
currently
limited
data
to
evaluate
the
impact
of
vaccination
on
health.
Our
objectives
were
(1)
prevalence
changes
following
against
COVID-19,
(2)
test
potential
risk
factors
for
any
such
changes,
and
(3)
identify
patterns
symptoms
in
participants’
written
accounts.
Methods
We
performed
a
secondary
analysis
retrospective
online
survey
titled
“The
Covid-19
Pandemic
Women’s
Reproductive
Health”,
conducted
March
2021
UK
before
widespread
media
attention
regarding
impacts
SARS-CoV-2
menstruation.
Participants
recruited
via
Facebook
ad
campaign
eligibility
criteria
completion
age
greater
than
18
years,
having
ever
menstruated
living
UK.
In
total,
26,710
people
gave
consent
completed
survey.
For
this
we
selected
4,989
participants
who
pre-menopausal
vaccinated.
These
aged
28
43,
predominantly
from
England
(81%),
white
background
(95%)
not
using
hormonal
contraception
(58%).
Findings
Among
vaccinated
individuals
(n=4,989),
80%
did
report
up
4
months
after
their
first
vaccine
injection.
Current
use
combined
oral
contraceptives
was
associated
with
lower
odds
reporting
by
48%
(OR
=
0.52,
95CI
[0.34
0.78],
P
<0.001).
Odds
increased
44%
current
smokers
1.44,
[1.07
1.94],
<0.01)
more
50%
positive
COVID
status
[Long
Covid
1.61,
[1.28
2.02],
<0.001),
acute
1.54,
[1.27
1.86],
<0.001)].
The
effects
remain
adjusting
self-reported
magnitude
over
year
preceding
Written
accounts
diverse
symptoms;
most
common
words
include
“cramps”,
“late”,
“early”,
“spotting”,
“heavy”
“irregular”,
low
level
clustering
among
them.
Conclusions
Following
disturbance
occurred
20%
sample.
Out
33
variables
investigated,
smoking
previous
history
infection
found
be
while
oestradiol-containing
protective
factor.
Diverse
experiences
reported,
bleeding
cessation
heavy
bleeding.
American Heart Journal Plus Cardiology Research and Practice,
Journal Year:
2021,
Volume and Issue:
3, P. 100011 - 100011
Published: March 1, 2021
The
COVID-19
pandemic
has
affected
millions
of
patients
across
the
globe.
Multiple
studies,
national
and
international
governmental
data
have
shown
important
sex
gender
differences
in
incidence
outcomes
with
COVID-19.
These
are
not
only
attributed
to
age
comorbid
conditions
but
likely
a
combination
factors,
including
hormonal
differences,
immune
response,
inflammatory
markers
behavioral
attitudes,
among
others.
In
this
review,
we
discuss
studies
addressing
sex-
gender-specific
infections
focus
on
potential
pathophysiological
mechanisms
these
differences.
Journal of Comparative Effectiveness Research,
Journal Year:
2022,
Volume and Issue:
11(9), P. 689 - 698
Published: May 5, 2022
Aim:
To
provide
a
comprehensive
understanding
of
the
varying
effects
SARS-CoV-2
infection
based
on
sex.
Methods:
A
PubMed
search
470
primary
articles
was
performed,
with
inclusion
relevance
(sex
differences
discussed
in
target
COVID
population)
and
redundancy.
queried
title
for
keywords
"SEX"
"COVID"
or
"SARS"
between
2020
2022.
Results:
For
COVID-19,
males
have
increased
risk
infectivity
intensive
care
unit
admission
worse
overall
outcomes
compared
females.
Genetic
predispositions,
sex
hormones,
immune
system
responses
non-biological
causes
all
contribute
to
disparity
COVID-19
sexes.
sex-related
determinants
morbidity
mortality
remain
unclear.
Conclusions:
Male
is
factor
several
related
COVID-19.
Investigating
impact
an
important
part
behavior
disease.
Future
work
needed
further
explore
these
relationships
optimize
management
patients
Journal of Endocrinological Investigation,
Journal Year:
2022,
Volume and Issue:
46(1), P. 89 - 101
Published: Aug. 9, 2022
Abstract
Purpose
While
SARS-CoV-2
infection
appears
not
to
be
clinically
evident
in
the
testes,
indirect
inflammatory
effects
and
fever
may
impair
testicular
function.
To
date,
few
long-term
data
of
semen
parameters
impairment
after
recovery
comprehensive
andrological
evaluation
recovered
patients
has
been
published.
The
purpose
this
study
was
investigate
whether
affect
male
reproductive
health.
Methods
Eighty
were
recruited
three
months
COVID-19
recovery.
They
performed
physical
examination,
ultrasound,
analysis,
sperm
DNA
integrity
(TUNEL),
anti-sperm
antibodies
(ASA)
testing,
sex
hormone
profile
(Total
testosterone,
LH,
FSH).
In
addition,
all
administered
International
Index
Erectile
Function
questionnaire
(IIEF-15).
Sperm
compared
with
two
age-matched
healthy
pre-COVID-19
control
groups
normozoospermic
(CTR1)
primary
infertile
(CTR2)
subjects.
Results
Median
values
from
subjects
within
WHO
2010
fifth
percentile.
Mean
percentage
fragmentation
(%SDF)
14.1
±
7.0%.
Gelatin
Agglutination
Test
(
GAT
)
positive
3.9%
blood
serum
samples,
but
no
plasma
sample
found.
Only
five
(6.2%)
had
total
testosterone
levels
below
laboratory
reference
range.
bilateral
volume
31.5
9.6
ml.
dysfunction
detected
30%
Conclusion
Our
remark
that
does
seem
cause
direct
damage
function,
while
transient.
It
is
possible
counsel
couples
postpone
research
parenthood
or
ART
procedures
around
infection.